3rd Quarter - Termination — BELL & LINDSAY, INC. (FORMERLY WHITE HO… for AMERITOX (2017)

Firm

BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.)

Client

AMERITOX

Income

$40,000

Expenses

—

Terminated

Aug 14, 2017

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Informing about the need for effective prescription drug monitoring to address the growing epidemic of prescription drug abuse.

Lobbyist	Covered position, as disclosed
MICHAEL BENSON HAYCOCK New	LegisInternSenReid/CommInternSenDemocraticMediaCenter
MARK F LINDSAY	EOP Office of Administration Director

Contacted: SENATE; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Indian Health Service; Health Resources & Services Administration (HRSA); Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.